Tudor Financial Inc. Purchases 4,497 Shares of iShares Biotechnology ETF $IBB

Tudor Financial Inc. lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 155.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,387 shares of the financial services provider’s stock after acquiring an additional 4,497 shares during the period. Tudor Financial Inc.’s holdings in iShares Biotechnology ETF were worth $1,247,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC lifted its holdings in shares of iShares Biotechnology ETF by 46,806.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after acquiring an additional 46,806 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $1,907,000. Central Pacific Bank Trust Division lifted its holdings in shares of iShares Biotechnology ETF by 296,500.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after acquiring an additional 14,825 shares during the period. WorthPointe LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $1,424,000. Finally, Tudor Investment Corp ET AL bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $931,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1%

Shares of iShares Biotechnology ETF stock opened at $170.66 on Friday. The company has a 50 day moving average of $170.28 and a 200-day moving average of $170.65. iShares Biotechnology ETF has a 1-year low of $123.61 and a 1-year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.